MIRA INFORM
REPORT
|
Report Date : |
19.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
MEGA PHARMACEUTICALS LIMITED |
|
|
|
|
Registered Office : |
27 K.M., |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment: |
2000 |
|
|
|
|
Com. Reg. No.: |
0041800 |
|
|
|
|
Legal Form : |
Non – Listed Public Limited Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical
Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name
MEGA
PHARMACEUTICALS LIMITED
Company Address
|
Registered
Address & Factory |
|
27 K.M., |
|
Tel # |
92 (42) 35322540, 35322541 |
|
Fax # |
92 (42) 35320520 |
|
Email |
Short Description Of Business
|
Nature of Business |
Engaged in manufacture
and marketing of Pharmaceutical Products |
|
Year Established |
2000 |
|
Registration # |
0041800 |
Branches
|
Address |
Plot No. 33, Block No.5, Sector B-1, Township, |
|
Tel # |
92 (42) 35152338, 35152339, 35152340 |
|
Fax # |
92 (42) 35116111 |
Auditors
|
Ford Rhodes Sidat Hyder & Co. (Chartered Accountants) |
Legal Status
Subject Company was established as a
Non-listed Public Limited Company in 2000
|
Authorized Capital |
Rs. 90,000,000/-
divided into 9,000,000 shares of Rs. 10/- each |
|
Issued & Paid up Capital |
Rs. 77,000,000/-
divided into 7,700,000 shares of Rs. 10/- each |
Details of Management
|
Names |
Designation |
|
Dr. Muhammad Tahir Azam Mr. Ahmed Khan Mr. Najeeb-Ul-Haq Mr. Abdul Samad Mr. Abdul Rehman Mr. Humayun Ikram Dr. Muhammad Tariq Dr. Babar Saeed Khan Mr. Abdul Aziz Zia Dr. Wali Muhammad Mujahid Mr. Muhammad Iqbal |
Chief Executive Director Director Director Director Director Director Director Director Director Director |
Shareholders
|
Names of Shareholders |
|
Dr. Muhammad Tahir Azam Mr. Ahmed Khan Mr. Najeeb-Ul-Haq Mr. Abdul Samad Mr. Abdul Rehman Mr. Humayun Ikram Dr. Muhammad Tariq Dr. Babar Saeed Khan Mr. Abdul Aziz Zia Dr. Wali Muhammad Mujahid Mr. Muhammad Iqbal |
Associates
Subsidiary
None
Associated Companies
(1) M/S
Cern ‘N’
(2)
Products
Engaged in manufacture and marketing of
Pharmaceutical Products by its brand names of BRAVOFEN, CARDIOVASTIN, CUROFAM,
DAISY, GLUCOBAN, LEOCIN, LOVA, MACROMAX, MEGADIP, MEGAFAST, MEGAFENAC,,MEGALOR,
MEGAMYCIN, MEGAPOL, MEGAPRIDE, MEGAPRIN, MEGAROX, MEGASAR, MEGATOP,
MEGAVASTATIN, MEGAVID, MEGAZIME, MEGAZOLE, MERRIC, MOVERA, OSTEOCAM, OSTEOSOFT,
RELIANCE, RITEFLOX, ROMAN
Number of Employees
168
Annual Production Volume
The capacity and production of the company’s plant is
indeterminable as it is multi-product and involves varying processes of
manufacturing.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2009 |
220,000,000/- (Estimated) |
Trade Suppliers (Foreign)
VAV
D.B. G
AMOLI ORGANICS
(PVT) LIMITED,
(4) DCM SHRIRAM
INDUSTRIES LIMITED,
Distributors
|
Mainly exist at
all major cities of |
Exporting Countries
|
Mainly to African Countries |
Bankers
(1) Bank Alfalah
Limited,
(2) Standard Chartered
(3) National Bank of
(4) Habib Bank Limited,
(5) Soneri Bank Limited,
Memberships
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 85.40 |
|
|
1 |
Rs. 137.78 |
|
Euro |
1 |
Rs. 116.12 |
Comments
Subject Company
was established in 2000 and is engaged in manufacture and marketing of
Pharmaceutical Products. Directors are reported as qualified, resourceful &
experienced businessmen. Trade relations are reported as fair. Subject can be
considered for normal business dealings at usual trade terms and conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.18 |
|
|
1 |
Rs.73.04 |
|
Euro |
1 |
Rs.61.43 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Company |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.